Allergy Partners Announces Topic of the Month: COPD vs. Asthma

ASHEVILLE, N.C., June 02, 2016 (GLOBE NEWSWIRE) -- Allergy Partners announces the first of an ongoing series of health related topics of the month, starting with COPD vs. Asthma. A common concern of patients is the difference between chronic obstructive pulmonary disease (COPD) and asthma. Although a detailed comparison is beyond the scope of this article, one can consider basic differences between the two conditions. Both diseases are considered to be “obstructive” lung diseases, meaning that patients have difficulty exhaling completely between breaths. Obstructive lung diseases can be diagnosed by lung testing called spirometry. In this test, patients exhale forcibly into a machine which measures the amount of air they exhale in 1 second (Forced Expiratory Volume-1 or FEV1), and the total amount of air they exhale in a breath (Forced Vital Capacity or FVC). The machine then calculates a ratio of how much air was exhaled in the first second vs. the total amount of air exhaled in the breath, which is called the FEV1/FVC ratio. Said a different way, most patients will exhale 70% or more of their breath in the first second of exhalation. If they do not, they are considered to have a form of obstructive lung disease, such as asthma or COPD.

Asthma typically, although not universally, presents at a younger age (<40 years old), and is associated with shortness of breath, coughing, wheezing, and chest tightness. Often, there are specific triggers for these symptoms, such as pollen exposure, exercise, fume exposure including tobacco smoke, or lung infections. Lung function testing, such as spirometry, in asthmatic patients is often normal when patients are in their usual state of health. However, lung function testing when patients are ill will show a decline in the amount of air exhaled in the first second (FEV1) or total amount of air exhaled in a breath (FVC). Medications such as albuterol can be given to asthmatic patients for testing, and an improvement in either their FEV1 or FVC by 12 % and 200 ml indicates the presence of asthma. Alternatively, diagnosis of asthma can be made by giving patients a medication such as methacholine, which causes a temporary decline in lung function in asthmatics. The most important feature of asthma is that patients will be able to complete correct their lung function with treatment, a term called “completely reversible airway obstruction and hyper responsiveness.”

Chronic Obstructive Pulmonary Disease (COPD) typically presents later in life (over age 40), and is also associated with shortness of breath, coughing, wheezing, and chest tightness. COPD more commonly has additional symptoms of sputum production and shortness of breath requiring short term oxygen use. Like asthmatics, patients may feel increased symptoms when exposed to triggers such as fumes, or with lung infections. Also, like asthmatics, patients with COPD will have a reduction in their ability to exhale, and will show reductions in airflow when tested with spirometry. However, unlike asthmatic patients, COPD patients will not be able to completely correct their lung function even with treatment. COPD is also associated with permanent structural changes in lung structure, which may be seen on radiological studies such as CT scans. Emphysema is one such permanent change, and is a condition of destruction of alveoli, which are the parts of the lung where oxygen is absorbed into the blood stream. Emphysema is often seen in the setting of COPD, and is rarely seen with asthma. Tobacco use is by far the most common cause for COPD in developed countries, but other causes for COPD do occur such as genetic conditions. Alpha-1 antitrypsin deficiency (A1AT) is an example of a genetic condition which causes COPD in patients. This condition can be diagnosed with a simple blood test, and treatment is available to allow patients with A1AT to maintain their lung function.

Importantly, asthma and COPD can co-exist in patients, and it can be difficult to sort out whether patients have one or both conditions. Allergist/immunologists are experts in this area of medicine, and are commonly consulted to help with the diagnosis and treatment of these conditions. Allergists can rely on spirometry testing as discussed, or may order additional lung testing, such as full pulmonary function tests (PFTs). Fortunately, both asthma and COPD have great treatments to allow patients to breathe at their best. To learn more, consult your trusted Allergy Partners physician or visit allergypartners.com.

Allergy Partners, P.A., is the nation's largest single specialty practice with multiple locations across the United States. We strive to be recognized as leaders in the development and delivery of high-quality health care for patients with asthma & allergic disease. Our vast care network of providers work together to promote education, research & innovation in the field of allergy & asthma care.

Contact Information Allergy Partners www.allergypartners.com PO Box 2407 Skyland, NC 28776 (828) 277-1300 NOVA MedMarket www.novamedmarket.com

Source:Allergy Partners